Syncom Healthcare Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Syncom Healthcare Stock Forecast and Price Target
Syncom Healthcare's stock price reaches the average target of 0.00 by 2025 as expected recently by notable experts, there would be a potential downside of approximately 0 from the last closing price in June, 2021. This possible increase is based on a high estimate of 0.00 and a low estimate of 0.00. If you're looking for information on Syncom Healthcare stock, consider checking out the forecasts for comparable firms such as NSEI:CIPLA.
N/A
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.50k | Buy/Sell | Rp1.52k | 5.52% |
| CIPLA Stock Forecast | Cipla | Outperform |
18
|
Rp1.40k | Buy/Sell | Rp1.43k | 7.04% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.21k | Buy/Sell | Rp5.67k | -2.50% |
| ZYDUSLIFE Stock Forecast | Zydus Lifesciences | Outperform |
18
|
Rp953.55 | Buy/Sell | Rp655.25 | -9.02% |
| 500420 Stock Forecast | Torrent Pharmaceuticals | Outperform |
18
|
Rp2.64k | Buy/Sell | Rp2.13k | 6.04% |
Syncom Healthcare Revenue Forecast for 2023 - 2025 - 2030
In the last year, Syncom Healthcare's Revenue has decreased by 90.86%, going from 200.45M to 18.32M. The next year looks promising for Syncom Healthcare, with analysts predicting Revenue of 200.45M – an increase of 994.16%. Over the next nine years, experts anticipate that Syncom Healthcare's Revenue will grow at a rate of 10716.67%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500257 Stock Forecast | Lupin | Hold |
12
|
Rp1.65k | Buy/Sell | Rp1.11k | -5.80% |
| AUROPHARMA Stock Forecast | Aurobindo Pharma | Outperform |
18
|
Rp1.15k | Buy/Sell | Rp1.09k | 1.95% |
| 500488 Stock Forecast | Abbott India | Outperform |
18
|
Rp26.42k | Buy/Sell | Rp24.75k | 11.68% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500660 Stock Forecast | GlaxoSmithKline Pharmaceutical... | Hold |
18
|
Rp2.09k | Buy/Sell | Rp1.78k | 1.10% |
| IPCALAB Stock Forecast | Ipca Laboratories | Hold |
18
|
Rp1.34k | Buy/Sell | Rp987.00 | -14.41% |
| 506943 Stock Forecast | J. B. Chemicals & Pharmaceutic... | Outperform |
18
|
Rp1.90k | Buy/Sell | Rp1.89k | 1.99% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AJANTPHARM Stock Forecast | Ajanta Pharma | Outperform |
18
|
Rp2.22k | Buy/Sell | Rp1.95k | 6.30% |
| GLENMARK Stock Forecast | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.06k | Buy/Sell | Rp767.80 | -14.44% |
| PFIZER Stock Forecast | Pfizer | Outperform |
18
|
Rp4.26k | Buy/Sell | Rp4.53k | 15.92% |
Syncom Healthcare EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Syncom Healthcare's EBITDA has grown by 93.78%, rising from -17.05M to -33.04M. The next year, 0 experts forecast that Syncom Healthcare's EBITDA will decrease by 48.40%, reaching -17.05M. In 2030, professionals predict that Syncom Healthcare's EBITDA will decrease by 17.91%, reaching -27.12M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APLLTD Stock Forecast | Alembic Pharmaceuticals | Hold |
16
|
Rp999.60 | Buy/Sell | Rp742.44 | -8.46% |
| 500674 Stock Forecast | Sanofi India | Outperform |
18
|
Rp8.32k | Buy/Sell | Rp8.61k | 10.16% |
| 500302 Stock Forecast | Piramal Enterprises | Hold |
18
|
Rp924.90 | Buy/Sell | Rp1.11k | 8.12% |
Syncom Healthcare EBIT Forecast for 2023 - 2025 - 2030
In the last year, Syncom Healthcare's EBIT has grown by 32.97%, rising from -39.83M to -52.96M. According to the 0 analysts polled, in the next year, Syncom Healthcare's EBIT will fall by 24.79%, reaching -39.83M. By 2030, professionals believe that Syncom Healthcare's EBIT will have decreased by 13.50%, falling to -45.81M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NATCOPHARM Stock Forecast | NATCO Pharma | Outperform |
16
|
Rp1.02k | Buy/Sell | Rp822.45 | -1.29% |
| 506820 Stock Forecast | AstraZeneca Pharma India | - |
18
|
Rp5.34k | Buy/Sell | Rp0.00 | -100.00% |
| 532482 Stock Forecast | Granules India | Buy |
18
|
Rp422.85 | Buy/Sell | Rp381.00 | 13.52% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 524742 Stock Forecast | Caplin Point Laboratories | Buy |
17
|
Rp1.36k | Buy/Sell | Rp1.47k | 13.78% |
| MARKSANS Stock Forecast | Marksans Pharma | Buy |
18
|
Rp165.80 | Buy/Sell | Rp55.00 | -100.00% |
| 500126 Stock Forecast | Procter & Gamble Health | - |
17
|
Rp4.92k | Buy/Sell | Rp5.62k | -100.00% |
.jpg)